Sensorion and Uconn Health Announce Identification of First Potential Biomarker for Noise-Induced Hearing Loss. pdfRead

Sensorion’s SENS-401 Reduces Hearing Loss in Preclinical Study When Oral Administration Initiated Up to Four Days after Acoustic Trauma. pdfRead

Sensorion confirme son éligibilité au dispositif PEA-PME. pdfLire

Sensorion reports full year 2017 results. pdfRead

Sensorion to present Data in Two Oral Sessions at the American Neurotology Society’s 2018 Spring Meeting. pdfRead


20190603 pipeline


Patient center

Corporate presentation

Next events